Stayso, I understand that a recent Nature article out of Wuhan...

Stayso,

I understand that a recent Nature article out of Wuhan provides evidence that patients with severe COVID-19 symptoms reach a point at which their cytokine levels stabilise (level '8', for instance), before their status goes one of two ways: If the level falls from 8, they will survive; if the cytokine levels increase to 10 or more, they will die.

Some companies are testing drugs that inhibit a particular cytokine, which has obvious limitations. The Hudson Institute has discovered that Veyonda inhibits STING, which cuts off the source of most if not all cytokines involved in respiratory distress. ​

From a treatment perspective, it is a good thing that cytokines get to level 8 because this means the immune system is fighting the virus. I expect Veyonda to only be used when cytokine levels reach a critical point of 10 or higher, when patients are destined to die. If Veyonda is effective, shutting down STING should allow cytokine levels to stabilise at 8 or below, whereupon the immune system would again fight the virus.